BR9809778A - Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico. - Google Patents

Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.

Info

Publication number
BR9809778A
BR9809778A BR9809778-4A BR9809778A BR9809778A BR 9809778 A BR9809778 A BR 9809778A BR 9809778 A BR9809778 A BR 9809778A BR 9809778 A BR9809778 A BR 9809778A
Authority
BR
Brazil
Prior art keywords
antibody
polypeptide
producing
expression vector
single chain
Prior art date
Application number
BR9809778-4A
Other languages
English (en)
Inventor
Scott R Presnell
Teresa Gilbert
Theodore E Whitmore
Donald C Foster
Charles E Hart
Joyce M Lehner
Theresa Martinez
Ross C Hoffmann
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of BR9809778A publication Critical patent/BR9809778A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Radar Systems Or Details Thereof (AREA)

Abstract

"POLINUCLEOTìDEO ISOLADO, VETOR DE EXPRESSãO, PEPTìDEO OU POLIPEPTìDEO ISOLADO, ANTICORPO, PROCESSO PARA PRODUZIR O MESMO, FRAGMENTOS DE ANTICORPOS, ANTICORPOS DE CADEIA úNICA OU ANTICORPOS HUMANIZADOS, E, ANTICORPO ANTI-IDIOTìPICO". Novos polipeptídeos zcyto7 de mamíferos, polinucleotídeos codificando os polipeptídeos e composições relacionadas e processos incluindo os anticorpos e anticorpos anti-idiotípicos.
BR9809778-4A 1997-04-25 1998-04-23 Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico. BR9809778A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4488697P 1997-04-25 1997-04-25
US84575397A 1997-04-25 1997-04-25
US854398A 1998-01-16 1998-01-16
US7167698P 1998-01-16 1998-01-16
PCT/US1998/008212 WO1998049310A1 (en) 1997-04-25 1998-04-23 Mammalian cytokine-like factor 7

Publications (1)

Publication Number Publication Date
BR9809778A true BR9809778A (pt) 2000-06-20

Family

ID=27485789

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809778-4A BR9809778A (pt) 1997-04-25 1998-04-23 Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.

Country Status (16)

Country Link
EP (1) EP0977861B1 (pt)
JP (1) JP4216343B2 (pt)
KR (1) KR20010012111A (pt)
CN (1) CN1258315A (pt)
AT (1) ATE269901T1 (pt)
AU (1) AU736362B2 (pt)
BR (1) BR9809778A (pt)
CA (1) CA2288360A1 (pt)
DE (1) DE69824719T2 (pt)
EA (1) EA199900869A1 (pt)
ES (1) ES2223127T3 (pt)
IL (1) IL132496A0 (pt)
NO (1) NO995182L (pt)
NZ (1) NZ500885A (pt)
PL (1) PL336470A1 (pt)
WO (1) WO1998049310A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
US6486301B1 (en) * 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
AU8571198A (en) * 1997-07-16 1999-02-10 Human Genome Sciences, Inc. Interleukin-20
US6562578B1 (en) 1999-01-11 2003-05-13 Schering Corporation IL-17-like cytokine binding compounds and antibodies
WO1999035267A1 (en) * 1998-01-09 1999-07-15 Immunex Corporation Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
ES2292242T5 (es) 1998-05-15 2011-05-04 Genentech, Inc. Utilizaciones terapéuticas de polipéptidos homólogos de il-17.
EP3112468A1 (en) * 1998-05-15 2017-01-04 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
EP1865061A3 (en) * 1998-05-15 2007-12-19 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
IL141869A0 (en) * 1998-09-17 2002-03-10 Zymogenetics Inc Mammalian transforming growth factor beta-9 (ztgfss9)
KR20010089764A (ko) * 1999-01-11 2001-10-08 둘락 노먼 씨. 인터류킨-17과 관련된 포유류의 사이토카인, 이를코딩하는 폴리뉴클레오티드 및 이의 용도
WO2000061754A2 (en) * 1999-04-09 2000-10-19 Curagen Corporation Human proteins and polynucleotides encoding them
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
JP2016047051A (ja) * 1999-12-23 2016-04-07 ジェネンテック， インコーポレイテッド Ｉｌ−１７相同的ポリペプチドとその治療上の用途
ES2333772T3 (es) * 1999-12-23 2010-03-01 Genentech, Inc. Polipeptidos homologos de il-17 y il-17r y sus utilizaciones terapeuticas.
US6569419B2 (en) 2000-02-29 2003-05-27 Zymogenetics, Inc. Methods for promoting production of myelin by Schwann cells
CA2401716A1 (en) * 2000-02-29 2001-09-07 Zymogenetics, Inc. Methods for promoting production of myelin by schwann cells
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20040234500A1 (en) * 2001-03-26 2004-11-25 Moore Emma E. Method for inducing proliferation of retinal stem cells
WO2002086087A2 (en) * 2001-04-20 2002-10-31 Zymogenetics, Inc. Cytokine protein family
US20070053872A1 (en) * 2005-08-04 2007-03-08 Moore Emma E Treatment of wounds using il-17b
JP2010509364A (ja) * 2006-11-08 2010-03-25 ザイモジェネティクス， インコーポレイテッド 創傷治癒における使用のためのｉｌ−１７ｂ
BRPI0908312A2 (pt) 2008-05-05 2015-08-18 Novimmune Sa '' anticorpo monoclonal totalmente humano isolado, composição farmacêutica, método de alívio de um sintoma de uma indicação clínica e método de alívio de um sintoma de uma doença autoimune, distúrbio inflamatório ou distúrbio da proliferação celular''
EP2427203B1 (en) 2009-05-05 2018-10-17 Novimmune S.A. Anti-il-17f antibodies and use thereof

Also Published As

Publication number Publication date
KR20010012111A (ko) 2001-02-15
IL132496A0 (en) 2001-03-19
ES2223127T3 (es) 2005-02-16
CN1258315A (zh) 2000-06-28
AU736362B2 (en) 2001-07-26
EP0977861A1 (en) 2000-02-09
DE69824719T2 (de) 2005-06-30
CA2288360A1 (en) 1998-11-05
JP2002509432A (ja) 2002-03-26
PL336470A1 (en) 2000-06-19
NO995182D0 (no) 1999-10-22
ATE269901T1 (de) 2004-07-15
AU7152798A (en) 1998-11-24
DE69824719D1 (de) 2004-07-29
WO1998049310A1 (en) 1998-11-05
EA199900869A1 (ru) 2000-12-25
JP4216343B2 (ja) 2009-01-28
NZ500885A (en) 2001-06-29
NO995182L (no) 1999-12-22
EP0977861B1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
BR9507618A (pt) Frações polipeptidicas solúveis da proteína lag-3 processo de produção composição terapêutica anticorpos anti-idiotipo
DE69841102D1 (de) Monoklonaler antikörper gegen ein prion protein und dessen verwendung zum nachweis von prionen
IL193886A0 (en) Antibodies that bind to ldcam sequences
WO1990010709A3 (en) Monoclonal antibodies for metallic cations on small molecules
NO995182D0 (no) Pattedyrcytokinlignende faktor 7
WO1998050433A3 (en) Human monoclonal antibodies to epidermal growth factor receptor
GEP20105118B (en) Anti-vegf antibodies
DE69839444D1 (de) Smad 6 und dessen anwendungen
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
IT1271461B (it) Anticorpo monoclonale bispecifico anti-cd3/anti-egfr,processo per la produzione e suo uso.
BR9500271B1 (pt) seqüência de dna recombinante, vetor, células procarióticas e de fungo transformadas e proteìna com atividade sacarose-isomerase e com atividade de platinase e/ou trehalulase.
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
PT759942E (pt) Receptor de interleucina-15
DE69333382D1 (de) Hyaluronan rezeptor (rezeptor durch hyaluronan verurzachte bewelichkeit) und hyaluronan bindende peptide
PL327066A1 (en) Method of diagnosing and treating squamous cell carcinomas
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
WO1999029720A3 (en) Mammalian alpha helical protein-1
AU5990100A (en) ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
DK599189A (da) Apo-ai-polypeptid og dets anvendelse, monoklonalt antistof, som reagerer dermed, samt hybridoma til dettes fremstilling
WO2001046419A3 (en) Mammalian prion proteins; related reagents and methods
ZA986064B (en) Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and their use.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.